サマリー

This report contains market size and forecasts of Therapeutic Enzyme Drugs in China, including the following market information:
China Therapeutic Enzyme Drugs Market Revenue, 2016-2021, 2022-2027, ($ millions)
China top five Therapeutic Enzyme Drugs companies in 2020 (%)
The global Therapeutic Enzyme Drugs market size is expected to growth from US$ XX million in 2020 to US$ XX million by 2027; it is expected to grow at a CAGR of XX% during 2021-2027.
The China Therapeutic Enzyme Drugs market was valued at US$ XX million in 2020 and is projected to reach US$ XX million by 2027, at a CAGR of XX% during the forecast period.
QYResearch has surveyed the Therapeutic Enzyme Drugs Companies and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
China Therapeutic Enzyme Drugs Market, By Type, 2016-2021, 2022-2027 ($ Millions)
China Therapeutic Enzyme Drugs Market Segment Percentages, By Type, 2020 (%)
Injectable
Oral
Topical

China Therapeutic Enzyme Drugs Market, By Application, 2016-2021, 2022-2027 ($ Millions)
China Therapeutic Enzyme Drugs Market Segment Percentages, By Application, 2020 (%)
Gaucher Disease
MPS Disease
Gastrointestinal Diseases
Others

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Therapeutic Enzyme Drugs revenues in China market, 2016-2021 (Estimated), ($ millions)
Key companies Therapeutic Enzyme Drugs revenues share in China market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sanofi
BioMarin
AbbVie
Shire
Alexion
Horizon Pharma
Allergan
Johnson & Johnson
Recordati Rare Diseases
Pfizer
Vivus
Digestive Care

ページTOPに戻る

目次

1 Introduction to Research & Analysis Reports
1.1 Therapeutic Enzyme Drugs Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 China Therapeutic Enzyme Drugs Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year

2 China Therapeutic Enzyme Drugs Overall Market Size
2.1 China Therapeutic Enzyme Drugs Market Size: 2021 VS 2027
2.2 China Therapeutic Enzyme Drugs Revenue, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints

3 Company Landscape
3.1 Top Therapeutic Enzyme Drugs Players in China Market
3.2 Top China Therapeutic Enzyme Drugs Companies Ranked by Revenue
3.3 China Therapeutic Enzyme Drugs Revenue by Companies
3.4 Top 3 and Top 5 Therapeutic Enzyme Drugs Companies in China Market, by Revenue in 2020
3.5 Companies Therapeutic Enzyme Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Therapeutic Enzyme Drugs Players in China Market
3.6.1 List of Tier 1 Therapeutic Enzyme Drugs Companies in China
3.6.2 List of Tier 2 and Tier 3 Therapeutic Enzyme Drugs Companies in China

4 Sights by Type
4.1 Overview
4.1.1 By Type - China Therapeutic Enzyme Drugs Market Size Markets, 2021 & 2027
4.1.2 Injectable
4.1.3 Oral
4.1.4 Topical
4.2 By Type - China Therapeutic Enzyme Drugs Revenue & Forecasts
4.2.1 By Type - China Therapeutic Enzyme Drugs Revenue, 2016-2021
4.2.2 By Type - China Therapeutic Enzyme Drugs Revenue, 2022-2027
4.2.3 By Type - China Therapeutic Enzyme Drugs Revenue Market Share, 2016-2027

5 Sights by Application
5.1 Overview
5.1.1 By Application - China Therapeutic Enzyme Drugs Market Size, 2021 & 2027
5.1.2 Gaucher Disease
5.1.3 MPS Disease
5.1.4 Gastrointestinal Diseases
5.1.5 Others
5.2 By Application - China Therapeutic Enzyme Drugs Revenue & Forecasts
5.2.1 By Application - China Therapeutic Enzyme Drugs Revenue, 2016-2021
5.2.2 By Application - China Therapeutic Enzyme Drugs Revenue, 2022-2027
5.2.3 By Application - China Therapeutic Enzyme Drugs Revenue Market Share, 2016-2027

6 Therapeutic Enzyme Drugs Companies Profiles
6.1 Sanofi
6.1.1 Sanofi Company Details
6.1.2 Sanofi Business Overview
6.1.3 Sanofi Therapeutic Enzyme Drugs Introduction
6.1.4 Sanofi Therapeutic Enzyme Drugs Revenue in China Market (2016-2021)
6.1.5 Sanofi Recent Developments
6.2 BioMarin
6.2.1 BioMarin Company Details
6.2.2 BioMarin Business Overview
6.2.3 BioMarin Therapeutic Enzyme Drugs Introduction
6.2.4 BioMarin Therapeutic Enzyme Drugs Revenue in China Market (2016-2021)
6.2.5 BioMarin Recent Developments
6.3 AbbVie
6.3.1 AbbVie Company Details
6.3.2 AbbVie Business Overview
6.3.3 AbbVie Therapeutic Enzyme Drugs Introduction
6.3.4 AbbVie Therapeutic Enzyme Drugs Revenue in China Market (2016-2021)
6.3.5 AbbVie Recent Developments
6.4 Shire
6.4.1 Shire Company Details
6.4.2 Shire Business Overview
6.4.3 Shire Therapeutic Enzyme Drugs Introduction
6.4.4 Shire Therapeutic Enzyme Drugs Revenue in China Market (2016-2021)
6.4.5 Shire Recent Developments
6.5 Alexion
6.5.1 Alexion Company Details
6.5.2 Alexion Business Overview
6.5.3 Alexion Therapeutic Enzyme Drugs Introduction
6.5.4 Alexion Therapeutic Enzyme Drugs Revenue in China Market (2016-2021)
6.5.5 Alexion Recent Developments
6.6 Horizon Pharma
6.6.1 Horizon Pharma Company Details
6.6.2 Horizon Pharma Business Overview
6.6.3 Horizon Pharma Therapeutic Enzyme Drugs Introduction
6.6.4 Horizon Pharma Therapeutic Enzyme Drugs Revenue in China Market (2016-2021)
6.6.5 Horizon Pharma Recent Developments
6.7 Allergan
6.7.1 Allergan Company Details
6.7.2 Allergan Business Overview
6.7.3 Allergan Therapeutic Enzyme Drugs Introduction
6.7.4 Allergan Therapeutic Enzyme Drugs Revenue in China Market (2016-2021)
6.7.5 Allergan Recent Developments
6.8 Johnson & Johnson
6.8.1 Johnson & Johnson Company Details
6.8.2 Johnson & Johnson Business Overview
6.8.3 Johnson & Johnson Therapeutic Enzyme Drugs Introduction
6.8.4 Johnson & Johnson Therapeutic Enzyme Drugs Revenue in China Market (2016-2021)
6.8.5 Johnson & Johnson Recent Developments
6.9 Recordati Rare Diseases
6.9.1 Recordati Rare Diseases Company Details
6.9.2 Recordati Rare Diseases Business Overview
6.9.3 Recordati Rare Diseases Therapeutic Enzyme Drugs Introduction
6.9.4 Recordati Rare Diseases Therapeutic Enzyme Drugs Revenue in China Market (2016-2021)
6.9.5 Recordati Rare Diseases Recent Developments
6.10 Pfizer
6.10.1 Pfizer Company Details
6.10.2 Pfizer Business Overview
6.10.3 Pfizer Therapeutic Enzyme Drugs Introduction
6.10.4 Pfizer Therapeutic Enzyme Drugs Revenue in China Market (2016-2021)
6.10.5 Pfizer Recent Developments
6.11 Vivus
6.11.1 Vivus Company Details
6.11.2 Vivus Business Overview
6.11.3 Vivus Therapeutic Enzyme Drugs Introduction
6.11.4 Vivus Therapeutic Enzyme Drugs Revenue in China Market (2016-2021)
6.11.5 Vivus Recent Developments
6.12 Digestive Care
6.12.1 Digestive Care Company Details
6.12.2 Digestive Care Business Overview
6.12.3 Digestive Care Therapeutic Enzyme Drugs Introduction
6.12.4 Digestive Care Therapeutic Enzyme Drugs Revenue in China Market (2016-2021)
6.12.5 Digestive Care Recent Developments

7 Conclusion
8 Appendix
8.1 Note
8.2 Examples of Clients
8.3 Author Details
8.4 Disclaimer